Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 272

1.

Stimulant drugs.

Santosh PJ, Taylor E.

Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I27-43. Review.

PMID:
11140778
[PubMed - indexed for MEDLINE]
2.

Treatment of attention-deficit/hyperactivity disorder.

Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R.

Evid Rep Technol Assess (Summ). 1999 Nov;(11):i-viii, 1-341.

PMID:
10790990
[PubMed - indexed for MEDLINE]
Free Article
3.

A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.

Foy JM, Earls MF.

Pediatrics. 2005 Jan;115(1):e97-104.

PMID:
15629972
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
[PubMed - indexed for MEDLINE]
5.

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.

Child Care Health Dev. 2006 Sep;32(5):575-83.

PMID:
16919137
[PubMed - indexed for MEDLINE]
6.

[Prescribing ritalin in combined modality management of hyperactivity with attention deficit].

Bricard C, Boidein F.

Encephale. 2001 Sep-Oct;27(5):435-43. French.

PMID:
11760693
[PubMed - indexed for MEDLINE]
7.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
[PubMed - indexed for MEDLINE]
8.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
[PubMed - indexed for MEDLINE]
9.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
[PubMed - indexed for MEDLINE]
10.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
11.

Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.

Stevenson RD, Wolraich ML.

Pediatr Clin North Am. 1989 Oct;36(5):1183-97. Review.

PMID:
2677938
[PubMed - indexed for MEDLINE]
12.

Attention-deficit/hyperactivity disorder.

Shaywitz BA, Fletcher JM, Shaywitz SE.

Adv Pediatr. 1997;44:331-67. Review.

PMID:
9265975
[PubMed - indexed for MEDLINE]
13.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
[PubMed - indexed for MEDLINE]
14.

The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder.

Kratochvil CJ, Greenhill LL, March JS, Burke WJ, Vaughan BS.

CNS Drugs. 2004;18(14):957-66. Review.

PMID:
15584766
[PubMed - indexed for MEDLINE]
15.

Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.

Connor DF.

J Dev Behav Pediatr. 2002 Feb;23(1 Suppl):S1-9. Review.

PMID:
11875284
[PubMed - indexed for MEDLINE]
16.

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.

Peterson K, McDonagh MS, Fu R.

Psychopharmacology (Berl). 2008 Mar;197(1):1-11. Epub 2007 Nov 17. Review.

PMID:
18026719
[PubMed - indexed for MEDLINE]
17.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
[PubMed - indexed for MEDLINE]
18.

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.

J Dev Behav Pediatr. 2006 Feb;27(1):1-10.

PMID:
16511362
[PubMed - indexed for MEDLINE]
19.

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.

Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K.

Am J Psychiatry. 2005 Sep;162(9):1628-36.

PMID:
16135621
[PubMed - indexed for MEDLINE]
20.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.

Pediatrics. 2001 Jun;107(6):E105.

PMID:
11389303
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk